Prometheus Biosciences In... (RXDX)
NASDAQ: RXDX
· Real-Time Price · USD
199.92
0.18 (0.09%)
At close: Jun 15, 2023, 10:00 PM
Prometheus Biosciences Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 |
Net Income | -150.56M | -141.75M | -132.91M | -122.96M | -108.32M | -90.19M | -68.9M | -48.51M | -37.95M | -37.14M | -28.52M |
Depreciation & Amortization | 775K | 629K | 502K | 411K | 306K | 258K | 203K | 155K | 126K | 109K | 79K |
Stock-Based Compensation | 26.96M | 20.86M | 16.39M | 16.62M | 13.19M | 10.7M | 8.54M | 2.47M | 1.42M | 739K | 440K |
Other Working Capital | 8.01M | 9.9M | 12.25M | 6.27M | 14.92M | 14.62M | 12.41M | 15.15M | 4.78M | 6.67M | 3.69M |
Other Non-Cash Items | 259K | -177K | 21.66M | 23.61M | 23.58M | 25.18M | 8.89M | 7.55M | 3.22M | 9.6M | 3.62M |
Deferred Income Tax | -6.64M | -1.64M | -22.26M | -22.26M | -22.26M | -22.26M | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -4.21M | -1.18M | 12.31M | 7.2M | 19.61M | 12.82M | 4.62M | 4.13M | -8.56M | -1.33M | 1.68M |
Operating Cash Flow | -133.41M | -123.25M | -104.31M | -97.39M | -73.9M | -63.51M | -46.65M | -34.21M | -41.75M | -28.02M | -22.7M |
Capital Expenditures | -2.28M | -2.7M | -2.52M | -2.4M | -1.79M | -1.14M | -925K | -598K | -331K | -204K | -225K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -753.08M | -478.68M | -190.49M | -115.97M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 160.2M | 77.6M | 9.25M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | 626K | 83K | 18K | -859K | -1.49M |
Investing Cash Flow | -595.16M | -403.78M | -183.77M | -118.37M | -1.79M | -1.14M | -299K | -515K | -313K | -1.06M | -1.71M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | 722K | 722K | 428K | 428K | 428K | 428K | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 614.88M | 562.2M | 87.37M | 7.33M | -8.51M | 267.69M | 312.7M | 319.62M | 320.9M | 79.89M | 34.37M |
Financial Cash Flow | 614.88M | 562.2M | 87.37M | 7.33M | -8.51M | 267.69M | 312.7M | 319.62M | 320.9M | 79.89M | 34.37M |
Net Cash Flow | -113.69M | 35.17M | -200.7M | -208.43M | -84.2M | 203.05M | 265.76M | 284.9M | 278.83M | 50.8M | 9.96M |
Free Cash Flow | -135.69M | -125.96M | -106.83M | -99.79M | -75.69M | -64.64M | -47.57M | -34.81M | -42.08M | -28.22M | -22.93M |